Skip to main content

Table 2 Overview of non-canonical splice-site variants in MYO15A

From: Addition of an affected family member to a previously ascertained autosomal recessive nonsyndromic hearing loss pedigree and systematic phenotype-genotype analysis of splice-site variants in MYO15A

 

Variant

Predicted effect on pre-mRNA splicing

Number of patients

 

In silico prediction

Minigene splicing assay

Zygosity

ACMG classification (Code)

CADD PHREAD

varSEAK Online

SpliceAI

MaxEntScan alt

MaxEntScan diff

MaxEntScan ret

1

c.3609+985G > A

Cryptic exon inclusion

8

18.5

Class 1: no splicing effect

Donor Loss: 0.27

N/A

N/A

N/A

No

Het/ Hom

LP

PS4+(PM2+PM3+PP1+PP3)

2

c.4142+5G > A

Exon Skipping

2

25.7

"Class 5: splicing effect (Loss of function for authentic Splice Site. Exon Skipping)

Donor Loss: 0.90

2.649

6.604

9.253

No

Hom

VUS

(PM2+PP3)

3

c.5134-10C > G

No splicing effect

1

4.72

Class 1: no splicing effect

0

11.18

1.105

12.288

No

Het

VUS

(PM2+BP4)

4

c.5964+3G > A

Exon Skipping

4

9.911

Class 2: likely no splicing effect

Donor Gain:0.34

9.65

-2.577

7.075

No

Het

LP

(PM2+PM3+PP1+PP3+PP5)

5

c.5965-8C > T

No splicing effect

1

2.737

Class 1: no splicing effect

Acceptor Gain:0.02

9.05

0.868

9.917

No

Het

VUS

(PM2+BP4)

6

c.6956+9C > G

Create ectopic splice site

2

22.4

"class 5: splicing effect (Use of a cryptic site 4 nt downstream of 3' ss

Donor Loss:0.66

N/A

N/A

N/A

No

Het

VUS

(PM2+PP3)

7

c.7395+3G > C

Create a cryptic splice donor site

1

15.82

Pos 6956+5: Strong increase of Score. New Splice Site.)"

Donor Loss:0.26

6.60

3.495

10.098

No

Hom

VUS

(PM2+PP3)

8

c.7395+3G > A

Exon skipping

1

11.53

"Class 5: splicing effect (Loss of function for authentic Splice Site. Exon Skipping

Acceptor Gain/Donor Gain:0.01

10.65

-0.548

10.098

No

Hom

VUS

(PM2+PP3)

9

c.7787+4A > G

Exon skipping

1

14.42

"Class 4: likely splicing effect (Likely loss of function for authentic Splice Site. Exon Skipping

Donor Loss:0.15

6.32

0.841

7.162

No

Hom

VUS

(PM2+PP3)

10

c.8224+3A > G

Exon Skipping

1

23.3

Pos 7787 + 1: Decrease of Score for authentic Splice Site.)"

Donor Loss:0.79

-4.99

5.665

0.674

No

Hom

VUS

(PM2+PP3)

11

c.8788+5G > T

Exon Skipping

1

22.8

"Class 4: likely splicing effect (Likely loss of function for authentic Splice Site. Exon Skipping

Donor Loss:0.82

-3.85

7.146

3.292

No

Hom

VUS

(PM2+PP3)

12

c.9083+6 T > A

Exon Skipping

1

23.9

Pos 8224 + 1: Decrease of Score for authentic Splice Site.)"

Donor Loss:0.71

3.73

4.554

8.281

Yes

Hom

LP

(PS3+PM2+PP1+PP5+BP4)

  1. N/A Not available; Het Heterozygous; Hom Homozygous; CADD scores greater than 20 are considered to be pathogenic; P Pathogenic; LP Likely pathogenic; VUS Variants with uncertain significance